Children’s Cancer Care

Through serving our healthcare customers worldwide, we learn about medical trends and needs — such as the void of new, innovative children’s cancer treatments.

Dell believes technology is a critical part of changing this void and enabling more effective treatment of disease. Part of our philanthropic contribution on improving healthcare is to focus on accelerating pediatric cancer treatment — and we’re starting with the children diagnosed globally each year with neuroblastoma, one of the deadliest forms of cancer.

Brooke's Story

Brooke’s story: A five-year old fighting pediatric cancer

Our Children’s Cancer Care initiative provides the following:

Our multimillion dollar, multiyear commitment: By applying our technology, expertise, donations and employee volunteerism, we hope to open new possibilities for children fighting cancer.

Dell cloud technology provides the power to do more for personalized medicine: We are developing and donating cloud technology that will provide needed computing power to empower researchers and ultimately allow patients quicker access to better treatment. Researchers are now able to analyze a patient’s molecular data — a process that used to take 10 days — in six hours.

Support for families: We support the needs of families and children affected by pediatric cancer through a variety of nonprofit partners around the world.


Multimillion dollar, multiyear commitment

With a multimillion dollar, multiyear commitment of technology solutions and employee volunteerism, our Children’s Cancer Care initiatives will help power clinical researchers and doctors around the world to:
  • Support research to identify and share personalized treatments in days instead of months
  • Expand the reach and impact of the world’s first Food and Drug Administration (FDA)-approved personalized medicine trial for pediatric cancer, a collaboration between the Translational Genomics Research Institute (TGen) and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC)
  • Dell is prioritizing neuroblastoma as the focus of this giving initiative because of the crucial and immediate role Dell can play by donating cloud technology, a key component in addressing the void of new and innovative treatments available for children with this devastating disease. Neuroblastoma strikes one in 100,000 children annually in the U.S. and can produce aggressive tumors that are unique to each child.
The U.S. FDA has approved only one new treatment for any type of childhood cancer since the 1980s, compared with 50 approved treatments for adult cancers in the same time period.



Dell cloud technology gives the power to do more for personalized medicine

The trial is based on research from a group of collaborating investigators who are developing a personalized medicine process that is intended to permit near "real-time" processing of information on patient tumors and prediction of best treatments for a specific patient. Prior to Dell sponsorship, the trial was funded primarily by parents of children with neuroblastoma and their foundations.

Specifically for this commitment, Dell is developing and donating cloud technology that will provide needed computing power to help increase TGen’s gene sequencing and analysis capacity by 1,200 percent and improve collaboration between the team working on the trial.

The end result: Patients garner quicker access to a personalized treatment plan backed by more solid, collective research.

In 2012, we also delivered the TGen-Dell KIDS Cloud, which stores massive amounts of clinical and molecular data, allowing researchers and medical professionals worldwide access to information that can be used to refine treatments.

Dell believes information technology is the foundation on which healthcare will move forward, transitioning from treating illness to managing wellness. Our giving program focused on children’s cancer research and our partnership with TGen are an example of our work to understand emerging healthcare challenges, to drive the global transformation to information-driven healthcare.

Cancer care infographic


Support for families

As part of Dell’s ongoing support of Children’s Cancer Care initiatives, Dell supports the needs of families and children affected by pediatric cancer through a variety of nonprofit partners around the world. We support nonprofits worldwide through activities such as providing remote learning for children facing treatment, connecting families who are living remotely while their children are getting the care they need, issuing grants to cover cancer treatment for those who cannot afford it, funding pediatric care facilities and supporting outreach work. In the U.S., our own team members also provide comfort and personal support to families living in homes away from home like the Ronald McDonald House. Learn More
What is neuroblastoma?

A family’s fight against neuroblastoma



 

Dell is helping fight pediatric cancer

Dell technology’s critical role in cancer treatment advancement

Dell technology and cancer experts discuss how Dell’s donation of customized technology will ultimately enable the reduction in time-to-targeted treatment for cancer, including neuroblastoma.

2012 corporate responsibility report